General Information
Revision date
2020-10-01
Product name
Posaconazole Injection Formulation
supplier name
Merck & Co., Inc
Icons in SDS
Company Information
company name
Merck & Co., Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@merck.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H361d, H372
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR 1910.1200) Skin sensitization Category 1 Reproductive toxicity Category 2 Specific target organ toxicity Category 1 (Adrenal gland, Bone marrow, Kidney, Liver, Nerv- - repeated exposure (Oral) ous system, Reproductive organs)
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H361d Suspected of damaging the unborn child. H372 Causes damage to organs (Adrenal gland, Bone marrow, Kidney, Liver, Nervous system, Reproductive organs) through prolonged or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapors. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves, protective clothing, eye protection and face protection.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P308 + P313 IF exposed or concerned: Get medical attention. P333 + P313 If skin irritation or rash occurs: Get medical atten- tion. P363 Wash contaminated clothing before reuse.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents and container to an approved waste disposal plant.
2.3 Other hazards
None known.
